A randomized, double-blind, placebo-controlled trial on the effect of intranasal corticosteroid as a treatment for moderate to severe obstructive sleep apnea with coexisting chronic rhinitis.,Asian Pacific Journal of Allergy and Immunology

当前位置： X-MOL 学术 › Asian Pac. J. Allergy Immunol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

A randomized, double-blind, placebo-controlled trial on the effect of intranasal corticosteroid as a treatment for moderate to severe obstructive sleep apnea with coexisting chronic rhinitis.
Asian Pacific Journal of Allergy and Immunology ( IF 5 ) Pub Date : 2020-08-23 , DOI: 10.12932/ap-070320-0785
Vorakamol Phoophiboon _{1,

2} , Kiat Ruxrungtham _{3,

4} , Dittapol Muntham ₅ , Naricha Chirakalwasan _{1,

2}

Affiliation

Chronic rhinitis is a common co-existing disease with obstructive sleep apnea (OSA). Current evidence on intranasal steroid efficacy as a treatment modality is scarce.

中文翻译：